Menarini Biotech (“MBH”) is a fast-growing, agile, fully integrated CDMO for biologics located in the greater Rome area, Italy. Established in 2003, Menarini Biotech’s mission is to provide fast and efficient, yet very customer-centric, world-class, high-quality, services for biotech companies from preclinical development to GMP manufacturing (Mammalian and Microbial) up to BSL-2. These include CHO cell line development and analytical development for standard and non-standard mAbs, and new molecular formats, e.g. bispecifics, ADCs, fusion proteins. Our Quality System complies with AIFA/EU GMP requirements.
Company Details
- Employees
- 90
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.menarini-biotech.com
- Keywords
- cdmo, biologics, biotechnology, gmp manufacturing.
Menarini Biotech Questions
Menarini Biotech's website is https://www.menarini-biotech.com
Menarini Biotech's LinkedIn profile is https://it.linkedin.com/company/menarini-biotech
Menarini Biotech has
90 employees.
View email and phone details for 90
employees at Menarini Biotech.
Menarini Biotech's industry is
Biotechnology Research
Menarini Biotech's top competitors are
Menarini Silicon Biosystems,
Angelini Pharma,
A.menarini Diagnostics,
Takis,
Menarini Group,
Alfasigma,
Chiesi Group,
Bsp Pharmaceuticals S.p.a.,
Irbm,
Reithera.
Menarini Biotech's categories are Biotechnology Research
Menarini Biotech's founding year is 2003
